ALPHA-NAPHTHOLBENZEIN, 97.0%, 5g

4-(3-Bromophenyl)benzaldehyde, 97%, 5g

3-(butyrylamino)-4-methylbenzoic acid, 95.0%, 5g

Piano obiettivo per contrasto di fase PLPH S100x/1,25

8-Bromo-6-methoxy-tetralin-1-one, 98%, 1g

Ethyl 3-(3-(tert-Butylthio)-5-methoxy-1H-indol-2-yl)-2,2-dimethylpropanoate, 98%, 250mg

(3R)-3-amino-3-(4-bromo-2-methylphenyl)propan-1-ol, 95%, 250mg

(R)-1-Methyl-5-oxopyrrolidine-2-carboxylic acid, 97.0%, 500mg

2-(6-Methoxypyridin-3-yl) ethanamine, 95.0%, 1g

Isopropyl Benzoate>99.0%(GC)25mL

4-Quinolinecarboxaldehyde, 95.0%, 1g

6-Chloro-1H-pyrazolo[4,3-c]pyridin-3-amine, 97%, 250mg

N-(4-Benzyloxytrityl)-N'-(2-nitrobenzenesulfonyl)-1,2-diaminoethane Resin cross-linked with 1% DVB (200-400mesh) (0.9-1.1mmol/g)1g